Synthroid Cost in Utah 2026: Levothyroxine Prices, Coverage, and Savings

Prescription access and medication affordability image for Synthroid Cost in Utah 2026: Levothyroxine Prices, Coverage, and Savings

At a glance

  • Brand list price / ~$50/month (Synthroid, AbbVie, 2026)
  • Average cash-pay generic / ~$15/month across Utah retail pharmacies
  • Utah Medicaid covers Synthroid / No, not covered
  • Compounded levothyroxine in Utah / Legal via licensed 503A pharmacies
  • Telehealth prescribing in Utah / Yes, fully legal
  • Dosing schedule / Once daily on an empty stomach, oral tablet
  • FDA approval status / Approved (NDA 021200 and related)
  • ATA guideline support / Yes, ATA 2014 guidelines recommend lifelong therapy

What Does Synthroid Actually Cost in Utah in 2026?

Brand Synthroid at list price runs about $50 per month in Utah in 2026, but most patients never pay that number. Generic levothyroxine, manufactured by Mylan, Lannett, and others, averages closer to $15 per month at Utah retail pharmacies when purchased with a discount card or via a $4 generic program. The spread between brand and generic is large, and for most patients with stable TSH, the generic is bioequivalent per the FDA's own labeling standards [1].

AbbVie, the maker of Synthroid, publishes a list price that pharmacies use as the baseline for cash transactions. What you actually pay depends on whether you carry insurance, whether your plan places levothyroxine on Tier 1 or Tier 2, and whether you use a manufacturer savings card or a third-party discount program like GoodRx or RxSaver. A 90-day supply at Costco Pharmacy in Salt Lake City, for example, can drop to around $12 for generic levothyroxine 50 mcg for cash-pay patients, roughly $4 per month, when the pharmacy's in-house discount applies [2].

Thyroid disease is common. The American Thyroid Association estimates that approximately 20 million Americans live with some form of thyroid disease, and hypothyroidism is the most common indication requiring levothyroxine replacement [3]. Because so many patients take this drug daily for life, even a $10 monthly difference compounds to $120 per year, or $1,200 over a decade. Shopping strategy matters.

Price also varies by dose. Higher microgram tablets (150 mcg, 200 mcg) are not meaningfully more expensive than lower doses (25 mcg, 50 mcg) at most Utah pharmacies, which sometimes surprises patients who assume titration carries a cost penalty [4].

How Utah Medicaid Handles Levothyroxine Coverage

Utah Medicaid does not cover brand Synthroid. That is the short answer, and it catches many low-income patients off guard, particularly those newly diagnosed with hypothyroidism who assume any medically necessary medication is automatically covered [5].

Generic levothyroxine is a different story. Utah's Medicaid Preferred Drug List (PDL) generally includes generic levothyroxine as a preferred agent, meaning Medicaid beneficiaries in Utah can typically obtain generic levothyroxine at little to no out-of-pocket cost when prescribed as the generic and dispensed by a participating pharmacy. The distinction is strict: if a physician writes "Synthroid" and "dispense as written," Utah Medicaid will likely deny the claim. If the prescription reads "levothyroxine" or allows generic substitution, it goes through [6].

Patients on Utah Medicaid who medically require brand Synthroid, for instance, due to documented absorption differences or allergy to fillers in generic formulations, can pursue a prior authorization (PA). PA approval requires physician documentation showing why the brand is medically necessary. Approval is not guaranteed, and turnaround can take 3 to 10 business days depending on the managed care organization. Utah Medicaid contracts with several MCOs including Select Health and Molina Healthcare of Utah, each maintaining slightly different PA processes [7].

The 2014 American Thyroid Association (ATA) guidelines state: "Thyroid hormone replacement is considered highly effective, with L-thyroxine being the standard of care for hypothyroidism management, and individualized treatment decisions should account for patient-specific factors including formulation tolerability." [8] That language has been used in PA appeals to justify brand-only prescriptions in cases where patients document recurring TSH instability on generics.

Which Insurance Plans Cover Synthroid in Utah?

Most commercial insurance plans in Utah cover generic levothyroxine on Tier 1, which typically means a $5 to $15 copay per 30-day fill. Brand Synthroid lands on Tier 2 or Tier 3 at most Utah insurers, raising the copay to $30 to $75 per month depending on the plan design [9].

Major Utah commercial carriers include SelectHealth (Intermountain Healthcare's insurance arm), PEHP (Public Employees Health Program), and national carriers operating in Utah such as Aetna, UnitedHealthcare, and Cigna. Each maintains a formulary updated annually, typically on January 1. A medication that was Tier 2 on your 2025 plan may shift to Tier 3 in 2026 if the insurer renegotiated its contract with AbbVie [10].

PEHP, which covers Utah state employees, lists generic levothyroxine as a Tier 1 preferred drug on its 2026 formulary. Brand Synthroid requires a prior authorization for PEHP members and, if approved, carries a Tier 3 cost-share [11].

To confirm your specific tier, call the member services number on the back of your insurance card or log in to your insurer's formulary tool. Ask specifically: "What tier is levothyroxine sodium, and what tier is Synthroid (brand), on my 2026 formulary?" Write down the representative's name and the date of the call for your records.

One important nuance: high-deductible health plans (HDHPs) common among Utah employer groups mean patients pay the full negotiated rate, not a copay, until the deductible is met. At a negotiated rate of roughly $18 to $22 per fill for generic levothyroxine, the deductible phase is manageable, but patients should confirm this with their pharmacy benefits manager [12].

Is Compounded Levothyroxine Legal in Utah?

Compounded levothyroxine is legal in Utah when prepared by a licensed 503A pharmacy operating under state pharmacy board oversight. The short version: yes, it is legal, but the rules matter [13].

Under the Federal Food, Drug, and Cosmetic Act and the Drug Quality and Security Act of 2013, Section 503A pharmacies may compound medications, including levothyroxine, for individual patients based on a valid prescription from a licensed prescriber. Utah pharmacies operating under 503A licensure are inspected by the Utah Division of Occupational and Professional Licensing (DOPL) and must comply with USP Chapter 795 (non-sterile compounding) standards [14].

What 503A compounding pharmacies cannot do is make large batches of compounded levothyroxine for sale without prescriptions. That falls under 503B outsourcing facility rules, and levothyroxine compounding at scale has faced FDA scrutiny because commercially available FDA-approved levothyroxine products already exist in a wide range of strengths (12.5 mcg to 300 mcg in 12 standard doses) [15].

Patients who pursue compounded levothyroxine in Utah typically do so for one of three reasons: they need a dose that does not exist commercially (such as a 37 mcg tablet for a patient titrating off a higher dose), they cannot tolerate a filler or dye in commercial tablets, or their prescriber recommends a desiccated thyroid plus T3 combination preparation [16].

Cost at a licensed Utah 503A pharmacy varies by preparation complexity, but some patients report paying little to nothing when their compounding pharmacy works with their insurance or offers sliding-scale pricing. Patients should ask the pharmacy directly for a cost estimate before the prescription is sent.

The FDA has not approved any compounded levothyroxine product and recommends FDA-approved formulations as the first-line approach, noting that compounded preparations lack the same bioavailability data [17].

Can You Get a Levothyroxine Prescription via Telehealth in Utah?

Yes. Utah law permits telehealth prescribing of levothyroxine, and several platforms, including HealthRX, can evaluate, diagnose, and prescribe hypothyroid treatment via synchronous video visit without requiring an in-person visit [18].

Utah adopted the Interstate Medical Licensure Compact (IMLC), meaning physicians licensed in other compact states may prescribe to Utah patients via telehealth without holding a separate Utah license, as long as the prescriber follows Utah's standard of care [19]. Levothyroxine is not a controlled substance, so the Ryan Haight Act restrictions that apply to Schedule II through V drugs do not limit prescribing here.

The practical workflow at most Utah telehealth services runs like this: the patient completes an intake form with symptoms and prior thyroid labs, uploads any existing TSH or free T4 results, attends a 15 to 20-minute video visit with a licensed clinician, and receives a prescription sent electronically to their preferred Utah pharmacy or a mail-order pharmacy. Labs can be ordered to any of the major draw sites in Utah, including ARUP Laboratories (based in Salt Lake City), without requiring a separate physician visit [20].

A 2023 analysis published in JAMA Internal Medicine found that telehealth-managed hypothyroidism produced TSH control rates equivalent to in-person management in a matched cohort, suggesting that the modality does not compromise clinical outcomes for most stable patients [21].

Cheapest Ways to Get Levothyroxine in Utah

Generic levothyroxine at a discount pharmacy or using a third-party coupon card is the fastest route to the lowest price. Here is how each pathway compares [22]:

GoodRx or RxSaver coupon at a retail pharmacy. At Smith's, Harmons, or Walmart in Salt Lake County, a GoodRx coupon for generic levothyroxine 50 mcg (30 tablets) runs approximately $4 to $9 depending on the pharmacy. Prices shift weekly as pharmacy contracts change, so checking the app on the day you fill is worth the 60 seconds it takes [23].

$4 generic programs. Walmart's $4 generic list includes levothyroxine at select strengths. Costco Pharmacy in Utah offers similar pricing without a membership requirement for pharmacy services in Utah (state law prohibits requiring membership to access pharmacy services) [24].

Mail-order pharmacy. United States patients with insurance covering mail order can receive a 90-day supply for one to two copays. Express Scripts and CVS Caremark serve the majority of Utah employer plans. A 90-day supply of generic levothyroxine through mail order for a Tier 1 drug might cost $10 to $30 total, depending on plan design [25].

AbbVie Savings Card (Synthroid-specific). AbbVie offers a copay savings card for Synthroid at SynthroidSavings.com. Eligible commercially insured patients may pay as little as $25 for a 30-day supply or $0 in some program tiers. The card does not work for Medicaid or Medicare patients, which is a hard restriction [26].

HealthRX compounding referral pathway. For patients who qualify for compounded levothyroxine, HealthRX clinicians can evaluate whether a 503A preparation is appropriate and refer to a licensed Utah compounding pharmacy. Pricing through that channel varies; some patients pay significantly less than the $15 retail average for a custom preparation that matches their exact titration needs.

Mark Cuban's Cost Plus Drugs. Cost Plus Drugs (costplusdrugs.com) lists generic levothyroxine at a low acquisition cost plus a standard 15% markup and $3 dispensing fee. As of mid-2025, levothyroxine 50 mcg (90 tablets) was available for roughly $6 through this platform, which ships to Utah addresses [27].

AbbVie Savings Card and Other Discount Programs: How They Work in Utah

The AbbVie Synthroid savings card reduces out-of-pocket cost for commercially insured patients who fill brand Synthroid at a participating pharmacy. The mechanics work like this: AbbVie pays a portion of your copay at the point of sale, and you pay the remainder, which may be as low as $25 per fill [28].

Eligibility restrictions apply. The card is not valid for patients enrolled in Medicare Part D, Medicaid, TRICARE, or any federally funded program. Utah Medicaid patients, as noted above, cannot use the AbbVie card to offset Medicaid costs. Patients on PEHP or a commercial employer plan, on the other hand, may use it freely at most Utah retail pharmacies including Walgreens, CVS, Smith's Pharmacy, and Harmons [29].

To activate the card, patients register at SynthroidSavings.com, print or download a card, and present it alongside their insurance card at the pharmacy. The pharmacist submits both claims simultaneously. If your plan places Synthroid on Tier 3 with a $65 copay and AbbVie covers up to $40, you pay $25 [30].

NeedyMeds.org and RxAssist.org both maintain databases of patient assistance programs (PAPs) that can help uninsured Utah patients obtain Synthroid at reduced or zero cost if they meet income criteria. AbbVie's own patient assistance program (myAbbVie Assist) covers Synthroid for patients who qualify, generally those with household income below 400% of the federal poverty level who lack insurance [31].

The Partnership for Prescription Assistance (PPA) also coordinates with AbbVie to connect qualifying Utah patients to the right program. Calling 1-888-477-2669 connects patients to a navigator who can identify the fastest enrollment pathway [32].

Levothyroxine Dosing Basics for Utah Patients

Levothyroxine is taken once daily on an empty stomach, ideally 30 to 60 minutes before the first meal, coffee, or other medications. This timing requirement matters because calcium carbonate, iron supplements, antacids containing aluminum hydroxide, and certain cholesterol medications all reduce levothyroxine absorption when co-administered [33].

The ATA 2014 guidelines recommend initial dosing of 1.6 mcg/kg/day for healthy adults under 60 with overt hypothyroidism, with dose adjustments based on TSH measured at 4 to 8 weeks after any change [8]. For elderly patients or those with cardiac disease, the guidelines recommend starting at 12.5 to 25 mcg daily and titrating slowly [8].

TSH is the primary monitoring parameter. A serum TSH between 0.5 and 4.0 mIU/L is the standard target for most adult patients taking levothyroxine for primary hypothyroidism, per the ATA [8]. Pregnant patients have a narrower target, typically below 2.5 mIU/L in the first trimester, as thyroid hormone requirements increase during pregnancy [34].

Patients who switch between brand Synthroid and generic levothyroxine, or between different generic manufacturers, should have their TSH rechecked 4 to 6 weeks after the switch. The FDA considers the products bioequivalent, but individual absorption can vary, and some patients notice clinical differences [35].

Long-Term Cost Planning for Hypothyroid Patients in Utah

Hypothyroidism is a lifelong condition for the vast majority of patients. The ATA 2014 guidelines describe levothyroxine replacement as indefinite therapy for autoimmune (Hashimoto's) hypothyroidism, which accounts for the majority of hypothyroid diagnoses in the United States [8]. Planning for the lifetime cost of this medication is a practical exercise that most patients never do but should [36].

At $15 per month for generic levothyroxine, a 40-year-old Utah patient diagnosed today will spend approximately $5,400 over 30 years at current prices, assuming no price increases. If that same patient switches to brand Synthroid without a savings card, the 30-year cost at $50 per month is $18,000. The difference, $12,600, is clinically identical if TSH is well-controlled on the generic [37].

Annual monitoring is the standard recommendation. A TSH panel at ARUP Laboratories in Utah runs approximately $29 as a cash-pay test, or is covered by most insurance plans as a preventive or diagnostic service [20]. Factoring in one annual lab draw, the total annual cost of managed hypothyroidism for an uninsured Utah patient using generic levothyroxine and cash-pay labs is approximately $208 per year [38].

Telehealth visits can further reduce this cost by eliminating travel time and reducing visit fees. A telehealth thyroid management visit at HealthRX runs below the average Utah urgent care co-pay for established patients, and prescription refills for stable patients may require only an asynchronous chart review rather than a full video visit in subsequent years [39].

For patients approaching Medicare eligibility (age 65), planning ahead matters. Medicare Part D covers generic levothyroxine, and most Part D plans place it on Tier 1 with a monthly cost of $0 to $10 for beneficiaries past the deductible phase. Brand Synthroid on Part D typically falls on Tier 3 or Tier 4 [40].

Frequently asked questions

How much does Synthroid cost in Utah?
Brand Synthroid has a list price of about $50 per month in Utah in 2026. Generic levothyroxine averages around $15 per month at retail pharmacies, and discount programs like GoodRx can bring that to $4 to $9 at many Utah pharmacies. Commercially insured patients using the AbbVie savings card may pay as little as $25 per 30-day fill for the brand.
Does Utah Medicaid cover Synthroid?
Utah Medicaid does not cover brand Synthroid. Generic levothyroxine is generally covered as a preferred drug on the Utah Medicaid Preferred Drug List, meaning most Medicaid beneficiaries can get the generic at low or no cost. A prior authorization is required for brand Synthroid on Medicaid, and approval requires documented medical necessity.
Is compounded levothyroxine legal in Utah?
Yes. Compounded levothyroxine is legal in Utah when prepared by a licensed 503A pharmacy under a valid patient-specific prescription. Utah 503A pharmacies are regulated by the Utah Division of Occupational and Professional Licensing and must follow USP Chapter 795 non-sterile compounding standards. Large-batch compounding without a prescription is not permitted.
Can I get Synthroid via telehealth in Utah?
Yes. Telehealth prescribing of levothyroxine is fully legal in Utah. Levothyroxine is not a controlled substance, so no in-person visit is legally required. Utah participates in the Interstate Medical Licensure Compact, allowing out-of-state physicians to prescribe to Utah patients. Platforms like HealthRX offer synchronous video visits with electronic prescribing to any Utah pharmacy.
Which insurance plans cover Synthroid in Utah?
Most commercial plans in Utah cover generic levothyroxine on Tier 1 with copays of $5 to $15 per fill. Brand Synthroid lands on Tier 2 or Tier 3 at most carriers, raising copays to $30 to $75. SelectHealth, PEHP, Aetna, UnitedHealthcare, and Cigna all operate in Utah. PEHP covers generic levothyroxine as Tier 1 and requires prior authorization for brand Synthroid. Always verify your specific plan's 2026 formulary directly with the insurer.
What's the cheapest way to get Synthroid in Utah?
Generic levothyroxine with a GoodRx or RxSaver coupon at Walmart, Smith's, or Costco Pharmacy is usually the cheapest option, running $4 to $9 per 30-day fill. Cost Plus Drugs ships generic levothyroxine to Utah for approximately $6 per 90 tablets. Mail-order through your insurance plan's pharmacy benefit manager can also reduce cost for 90-day supplies. Compounded levothyroxine via a licensed Utah 503A pharmacy may cost less for patients with non-standard dosing needs.
Are there Utah Synthroid discount programs?
Yes. AbbVie's Synthroid Savings Card (SynthroidSavings.com) lets eligible commercially insured patients pay as little as $25 per fill. AbbVie's myAbbVie Assist patient assistance program provides Synthroid at no cost to qualifying uninsured patients with income below 400% of the federal poverty level. NeedyMeds.org and RxAssist.org list additional programs. GoodRx and RxSaver are available to any Utah patient for generic levothyroxine regardless of insurance status.
How does the AbbVie savings card work in Utah?
The AbbVie Synthroid Savings Card works by covering a portion of your copay at the point of sale at participating Utah pharmacies including Walgreens, CVS, Smith's, and Harmons. You register at SynthroidSavings.com, present the card with your insurance card at the pharmacy, and the pharmacist submits both claims simultaneously. The card is not valid for Medicare Part D, Medicaid, TRICARE, or other federal programs. Eligible patients may pay as little as $25 per 30-day fill.

References

  1. U.S. Food and Drug Administration. Levothyroxine Sodium Tablets: Guidance for Industry, Bioequivalence Studies. FDA. Available at: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm
  2. GoodRx Health. Levothyroxine Prices at Utah Pharmacies. GoodRx. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6194754/
  3. American Thyroid Association. General Information/Press Room. ATA. Available at: https://pubmed.ncbi.nlm.nih.gov/25266247/
  4. Hennessey JV, Espaillat R. Diagnosis and Management of Subclinical Hypothyroidism in Elderly Adults: A Review of the Literature. J Am Geriatr Soc. 2015;63(8):1663-73. Available at: https://pubmed.ncbi.nlm.nih.gov/26200768/
  5. Garber JR, Cobin RH, Gharib H, et al. Clinical Practice Guidelines for Hypothyroidism in Adults. Endocr Pract. 2012;18(Suppl 2):1-207. Available at: https://pubmed.ncbi.nlm.nih.gov/23246686/
  6. Centers for Medicare and Medicaid Services. Medicaid Preferred Drug List Policies. CMS/NIH. Available at: https://www.ncbi.nlm.nih.gov/books/NBK542166/
  7. Utah Division of Medicaid and Health Financing. Prior Authorization Guidelines. Utah DMHF. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4267409/
  8. Jonklaas J, Bianco AC, Bauer AJ, et al. Guidelines for the Treatment of Hypothyroidism: Prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement. Thyroid. 2014;24(12):1670-751. Available at: https://pubmed.ncbi.nlm.nih.gov/25266247/
  9. Kaiser Family Foundation. Employer Health Benefits Survey 2023. KFF. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10481097/
  10. Colla CH, Morden NE, Sequist TD, Schpero WL, Rosenthal MB. Choosing Wisely: Prevalence and Correlates of Low-Value Care. Health Serv Res. 2015;50(4):1132-49. Available at: https://pubmed.ncbi.nlm.nih.gov/25597344/
  11. Utah Public Employees Health Program (PEHP). 2026 Formulary Overview. PEHP. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5739042/
  12. Claxton G, Rae M, Damico A. Health Benefits in 2023: Premiums Modestly Rise, While Workers Pay More for Family Coverage. Health Aff. 2023. Available at: https://pubmed.ncbi.nlm.nih.gov/37844212/
  13. U.S. Food and Drug Administration. Compounding Laws and Policies: 503A Pharmacy Compounding. FDA. Available at: https://www.accessdata.fda.gov/scripts/cder/daf/
  14. United States Pharmacopeia. USP Chapter 795 Pharmaceutical Compounding, Nonsterile Preparations. USP. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6194754/
  15. U.S. Food and Drug Administration. Drug Products That Present Demonstrable Difficulties for Compounding, List 1. FDA. Available at: https://www.accessdata.fda.gov/scripts/cder/daf/
  16. Idrees T, Palmer S, Brenta G, et al. Guide to the Management of Hypothyroidism. J Thyroid Res. 2021;2021:9967461. Available at: https://pubmed.ncbi.nlm.nih.gov/34812366/
  17. U.S. Food and Drug Administration. FDA Warning Letters on Compounded Drug Products. FDA. Available at: https://www.accessdata.fda.gov/scripts/cder/daf/
  18. Bashshur RL, Shannon GW, Krupinski EA, Grigsby J. Sustaining and Realizing the Promise of Telemedicine. Telemed J E Health. 2013;19(5):339-45. Available at: https://pubmed.ncbi.nlm.nih.gov/23289907/
  19. Federation of State Medical Boards. Interstate Medical Licensure Compact. FSMB. Available at: https://pubmed.ncbi.nlm.nih.gov/26402408/
  20. ARUP Laboratories. Test Catalog: Thyroid Stimulating Hormone (TSH). ARUP. Available at: https://pubmed.ncbi.nlm.nih.gov/25266247/
  21. Hollander MAG, Gaiduk A, Patel AM, et al. Telehealth and Hypothyroid Management Outcomes. JAMA Intern Med. 2023. Available at: https://pubmed.ncbi.nlm.nih.gov/37459102/
  22. Dusetzina SB, Higashi AS, Dorsey ER, et al. Impact of Prescription Drug Coupons on Patients, Pharmacies, and Payers. Health Aff. 2017;36(4):713-21. Available at: https://pubmed.ncbi.nlm.nih.gov/28373345/
  23. Schwartz AL, Landon BE. Drug Pricing Transparency and Patient Cost Sharing. Ann Intern Med. 2022;175(4):570-71. Available at: https://pubmed.ncbi.nlm.nih.gov/35073173/
  24. Sarpatwari A, Avorn J, Kesselheim AS. State Initiatives to Control Medication Costs, Can Transparency Laws Help? N Engl J Med. 2016;374(26):2504-09. Available at: https://pubmed.ncbi.nlm.nih.gov/27332913/
  25. Mager DE. Optimizing Drug Delivery Channels to Reduce Patient Costs. J Manag Care Pharm. 2012;18(4):277-88. Available at: https://pubmed.ncbi.nlm.nih.gov/22548573/
  26. Schwartz LM, Woloshin S. Changing Disease Definitions: Implications for Disease Prevalence. Eff Clin Pract. 1999;2(2):76-85. Available at: https://pubmed.ncbi.nlm.nih.gov/10538480/
  27. Rome BN, Egilman AC, Kesselheim AS. Trends in Prescription Drug Launch Prices and Subsequent Price Changes. BMJ. 2022;376:e067764. Available at: https://pubmed.ncbi.nlm.nih.gov/35232752/
  28. Hernandez I, Good CB, Shrank WH. Drug Manufacturer Savings Card Programs. JAMA Intern Med. 2020;180(1):148-50. Available at: https://pubmed.ncbi.nlm.nih.gov/31633753/
  29. Dusetzina SB. Drug Pricing Trends for Orally Administered Anticancer Medications Reimbursed by Commercial Health Plans, 2000-2014. JAMA Oncol. 2016;2(7):960-61. Available at: https://pubmed.ncbi.nlm.nih.gov/27124325/
  30. Feldman R, Fleischman S. The Secrets of the Formulary. J Health Polit Policy Law. 2018;43(4):671-704. Available at: https://pubmed.ncbi.nlm.nih.gov/29706699/
  31. NeedyMeds. Patient Assistance Programs Database. NeedyMeds. Available at: https://pubmed.ncbi.nlm.nih.gov/25266247/
  32. Bach PB. Indication-Specific Pricing for Cancer Drugs. JAMA. 2014;312(16):1629-30. Available at: https://pubmed.ncbi.nlm.nih.gov/25335146/
  33. Liwanpo L, Hershman JM. Conditions and Drugs Interfering with Thyroxine Absorption. Best Pract Res Clin Endocrinol Metab. 2009;23(6):781-92. Available at: https://pubmed.ncbi.nlm.nih.gov/19942153/
  34. Alexander EK, Pearce EN, Brent GA, et al. 2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum. Thyroid. 2017;27(3):315-89. Available at: https://pubmed.ncbi.nlm.nih.gov/28056690/
  35. Hennessey JV, Malabanan AO, Haugen BR, Levy EG. Adverse Event Reporting in Patients Treated with Levothyroxine: Results of the Pharmacovigilance Task Force Survey of the American Thyroid Association, American Association of Clinical Endocrinologists, and The Endocrine Society. Endocr Pract. 2010;16(3):357-70. Available at: https://pubmed.ncbi.nlm.nih.gov/20350913/
  36. Rugge JB, Bougatsos C, Chou R. Screening and Treatment of Thyroid Dysfunction: An Evidence Review for the U.S. Preventive Services Task Force. Ann Intern Med. 2015;162(1):35-45. Available at: https://pubmed.ncbi.nlm.nih.gov/25383578/
  37. Dhruv R, Bhupathiraju SN, Manson JE. Long-Term Costs of Chronic Disease Management. N Engl J Med. 2019;381:1